PubMed

Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes.

de Beaufort CE, Swift PG, Skinner CT, Aanstoot HJ, Aman J, Cameron F, Martul P, Chiarelli F, Daneman D, Danne T, Dorchy H, Hoey H, Kaprio EA, Kaufman F, Kocova M, Mortensen HB, Njølstad PR, Phillip M, Robertson KJ, Schoenle EJ, Urakami T, Vanelli M; Hvidoere Study Group on Childhood Diabetes 2005.

Diabetes Care. 2007 Sep;30(9):2245-50. Epub 2007 May 31.PMID: 17540955 [PubMed - indexed for MEDLINE]Related articlesFree article

Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group.

Danne T, Mortensen HB, Hougaard P, Lynggaard H, Aanstoot HJ, Chiarelli F, Daneman D, Dorchy H, Garandeau P, Greene SA, Hoey H, Holl RW, Kaprio EA, Kocova M, Martul P, Matsuura N, Robertson KJ, Schoenle EJ, Søvik O, Swift PG, Tsou RM, Vanelli M, Aman J; Hvidøre Study Group on Childhood Diabetes.

Diabetes Care. 2001 Aug;24(8):1342-7.PMID: 11473067 [PubMed - indexed for MEDLINE]Related articlesFree article

Associations between physical activity, sedentary behavior, and glycemic control in a large cohort of adolescents with type 1 diabetes: the Hvidoere Study Group on Childhood Diabetes.

Aman J, Skinner TC, de Beaufort CE, Swift PG, Aanstoot HJ, Cameron F; Hvidoere Study Group on Childhood Diabetes.

Pediatr Diabetes. 2009 Jun;10(4):234-9. Epub 2009 Jan 7.PMID: 19140898 [PubMed - indexed for MEDLINE]Related articles

Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes: response to de Beaufort et al.

Chalew S.

Diabetes Care. 2008 Apr;31(4):e27; author reply e28. No abstract available. PMID: 18375428 [PubMed - indexed for MEDLINE]Related articlesFree article

Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group.

Rosilio M, Cotton JB, Wieliczko MC, Gendrault B, Carel JC, Couvaras O, Ser N, Bougnères PF, Gillet P, Soskin S, Garandeau P, Stuckens C, Le luyer B, Jos J, Bony-Trifunovic H, Bertrand AM, Leturcq F, Lafuma A.

Diabetes Care. 1998 Jul;21(7):1146-53.PMID: 9653610 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.

Craig ME, Jones TW, Silink M, Ping YJ.

J Diabetes Complications. 2007 Sep-Oct;21(5):280-7.PMID: 17825751 [PubMed - indexed for MEDLINE]Related articles

A1C in children and adolescents with diabetes in relation to certain clinical parameters: the Swedish Childhood Diabetes Registry SWEDIABKIDS.

Hanberger L, Samuelsson U, Lindblad B, Ludvigsson J; Swedish Childhood Diabetes Registry SWEDIABKIDS.

Diabetes Care. 2008 May;31(5):927-9. Epub 2008 Jan 30.PMID: 18235047 [PubMed - indexed for MEDLINE]Related articlesFree article

Flexible intensive insulin therapy in adults with type 1 diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis.

Sämann A, Mühlhauser I, Bender R, Hunger-Dathe W, Kloos C, Müller UA.

Diabetes Care. 2006 Oct;29(10):2196-9.PMID: 17003292 [PubMed - indexed for MEDLINE]Related articlesFree article

Adverse events and their association with treatment regimens in the diabetes control and complications trial.

[No authors listed]

Diabetes Care. 1995 Nov;18(11):1415-27.PMID: 8722064 [PubMed - indexed for MEDLINE]Related articles

Metabolic control in children and adolescents with diabetes: experience of two Italian Regional Centers.

Vanelli M, Chiarelli F, Chiari G, Tumini S, Costi G, di Ricco L, Zanasi P, Catino M, Capuano C, Porcelli C, Adinolfi B, Cieri F, Giacalone T, Casani A.

J Pediatr Endocrinol Metab. 1999 May-Jun;12(3):403-9.PMID: 10821220 [PubMed - indexed for MEDLINE]Related articles

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

Survey on acute and chronic complications in children and adolescents with type 1 diabetes at Muhimbili National Hospital in Dar es Salaam, Tanzania.

Majaliwa ES, Munubhi E, Ramaiya K, Mpembeni R, Sanyiwa A, Mohn A, Chiarelli F.

Diabetes Care. 2007 Sep;30(9):2187-92. Epub 2007 Jun 11.PMID: 17563337 [PubMed - indexed for MEDLINE]Related articlesFree article

Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.

Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA.

Diabetes Technol Ther. 2008 Oct;10(5):377-83.PMID: 18715214 [PubMed - indexed for MEDLINE]Related articles

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

[Switching of NPH insulin to glargine therapy in a cohort of diabetic patients: observational study]

Maia FF, Melo FJ, Araújo IM, Araújo LR.

Arq Bras Endocrinol Metabol. 2007 Apr;51(3):426-30. Portuguese. PMID: 17546241 [PubMed - indexed for MEDLINE]Related articlesFree article

Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial.

Laffel LM, Hsu WC, McGill JB, Meneghini L, Volkening LK.

Diabetes Technol Ther. 2007 Jun;9(3):254-64.PMID: 17561796 [PubMed - indexed for MEDLINE]Related articles

The rate of improvement in metabolic control in children with diabetes mellitus type 1 on insulin glargine depends on age.

Deja G, Jarosz-Chobot P, Polanska J.

Exp Clin Endocrinol Diabetes. 2007 Nov;115(10):662-8.PMID: 18058601 [PubMed - indexed for MEDLINE]Related articles

Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.

Mullins P, Sharplin P, Yki-Jarvinen H, Riddle MC, Haring HU.

Clin Ther. 2007 Aug;29(8):1607-19.PMID: 17919543 [PubMed - indexed for MEDLINE]Related articles

Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus.

Chase HP, Arslanian S, White NH, Tamborlane WV.

J Pediatr. 2008 Oct;153(4):547-53. Epub 2008 Jun 27.PMID: 18589448 [PubMed - indexed for MEDLINE]Related articles

Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.

Deiss D, Kordonouri O, Hartmann R, Hopfenmüller W, Lüpke K, Danne T.

Pediatr Diabetes. 2007 Jun;8(3):157-62.PMID: 17550426 [PubMed - indexed for MEDLINE]Related articles